| Original language | English (US) |
|---|---|
| Pages (from-to) | 1514-1515 |
| Number of pages | 2 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 121 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2008 |
Bibliographical note
Funding Information:Supported by the National Heart, Lung, and Blood Institute through grant R01 HL68201-01A1.
Funding Information:
Disclosure of potential conflict of interest: A. D. Paltiel has received research support from the National Institutes of Health. S. T. Weiss has received research support from the National Institutes of Health and Genentech. A. L. Fuhlbrigge is on the speakers' bureau for GlaxoSmithKline and Merck, designed and analyzed studies for Novartis, was a member of Sepracor's Data Safety Monitoring Board, and has received research support from Boehringer Ingelheim, GlaxoSmithKline, and Merck. The rest of the authors have declared that they have no conflict of interest.